Announcement Date: April 20, 2016
The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) issues a recall for one batch of Taxotere over a potential risk that the solution may contain over-concentrated amounts of the drug’s active ingredient, docetaxel.